Holen Sie sich die Stockscreener-App
31.12
4.33%
-1.41
Handel nachbörslich:
31.00
-0.12
-0.39%
Avidity Biosciences Inc Aktie (RNA) Neueste Nachrichten
Avidity Biosciences Announces Inducement Grants -February 21, 2025 at 05:50 pm EST - Marketscreener.com
Biotech Talent Wars: Avidity Secures 22 Key Hires With Million-Dollar Equity Package - StockTitan
Avidity Biosciences (RNA) Projected to Post Earnings on Wednesday - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Given Average Rating of "Buy" by Analysts - MarketBeat
(RNA) Proactive Strategies - Stock Traders Daily
Legato Capital Management LLC Invests $301,000 in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Stock Price Down 7%Here's Why - MarketBeat
abrdn plc Boosts Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Kathleen P. Gallagher Sells 5,875 Shares - MarketBeat
(RNA) Investment Report - Stock Traders Daily
RNA Drug Development Pioneer Joins Codexis: Oligonucleotide Expert Who Created First Approved Antisense Drugs - StockTitan
Avidity Biosciences chief program officer sells $188,918 in stock - MSN
Avidity Biosciences chief program officer sells $188,918 in stock By Investing.com - Investing.com UK
We're Hopeful That Avidity Biosciences (NASDAQ:RNA) Will Use Its Cash Wisely - Yahoo Finance
How to Take Advantage of moves in (RNA) - Stock Traders Daily
Avidity Biosciences (NASDAQ:RNA) Stock Price Up 6%Here's Why - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Avidity Biosciences CEO Sarah Boyce sells $297k in stock - MSN
Avidity Biosciences' chief medical officer sells shares totaling $112,856 - MSN
Assenagon Asset Management S.A. Invests $1.18 Million in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock - MSN
Avidity Biosciences chief scientific officer sells shares worth $162,191 - MSN
Avidity Biosciences director sells $53,536 in stock - MSN
Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 3,287 Shares - MarketBeat
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 2,959 Shares of Stock - MarketBeat
Sarah Boyce Sells 10,397 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock By Investing.com - Investing.com Canada
Arthur A. Levin Sells 1,872 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat
Avidity Biosciences director sells $53,536 in stock By Investing.com - Investing.com Canada
Avidity Biosciences CFO sells $93,985 in stock By Investing.com - Investing.com Canada
Avidity Biosciences chief program officer sells shares worth $206,799 By Investing.com - Investing.com Canada
Avidity Biosciences chief program officer sells shares worth $206,799 - Investing.com India
Avidity Biosciences CEO Sarah Boyce sells $297k in stock By Investing.com - Investing.com UK
Avidity Biosciences' chief medical officer sells shares totaling $112,856 By Investing.com - Investing.com UK
Analysts Offer Predictions for RNA FY2025 Earnings - MarketBeat
Leerink Partnrs Has Negative Estimate for RNA Q1 Earnings - MarketBeat
Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) - MarketBeat
Avidity Biosciences Announces Inducement Grants Under Nasdaq Lis - GuruFocus.com
Exciting News from Avidity Biosciences! New Opportunities Await! - qhubo.com.ni
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StreetInsider.com
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):